Tagworks Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. Tagworks develops In vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. The company’s facilities are located at the Radboud University Medical Center in Nijmegen. Founded in 2011, Tagworks is a spin-out of Philips Healthcare, and originates from Philips’ molecular imaging expertise.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical
Founded
2011
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Tagworks Pharmaceuticals headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $2.1B in funding across 32 round(s). With a team of 11-50 employees, Tagworks Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Tagworks Pharmaceuticals, raised $65.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
7
Lead Investors
0
Total Funding Amount
$65.0M
Details
2
Tagworks Pharmaceuticals has raised a total of $65.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | |||
| 2023 | Early Stage Venture | 65.0M |
Investors
Tagworks Pharmaceuticals is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Gilde Healthcare | - | FUNDING ROUND - Gilde Healthcare | 65.0M |
| Michele Park | - | FUNDING ROUND - Michele Park | 65.0M |
| New Enterprise Associates | - | FUNDING ROUND - New Enterprise Associates | 65.0M |
| Tagworks Pharmaceuticals | - | FUNDING ROUND - Tagworks Pharmaceuticals | 65.0M |
Recent Activity
There is no recent news or activity for this profile.